252 related articles for article (PubMed ID: 7975390)
1. [The use of induced and spontaneous animal neoplasms in the experimental therapy of tumors].
Anikin IV; Pliss GB; Vlasov NN
Vopr Onkol; 1993; 39(4-6):161-8. PubMed ID: 7975390
[No Abstract] [Full Text] [Related]
2. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
[TBL] [Abstract][Full Text] [Related]
3. [Carcinostatic action of synthetic polymers on transplantable tumors].
Korosteleva TA; Movsesian KA; Meiia NV; Nesterova VI; Sorokin AIa
Vopr Onkol; 1982; 28(6):39-41. PubMed ID: 7090295
[No Abstract] [Full Text] [Related]
4. [Ways to overcome the contradictions between the experimental and clinical chemotherapy of tumors].
Syrkin AB
Vopr Onkol; 1990; 36(6):740-4. PubMed ID: 2378096
[No Abstract] [Full Text] [Related]
5. [The use of peptide preparations of the epiphysis (pineal gland) in oncology: 20 years' experience of research on epithalamin].
Anisimov VN; Khavinson VKh
Vopr Onkol; 1993; 39(4-6):131-42. PubMed ID: 7975386
[No Abstract] [Full Text] [Related]
6. [New approaches in experimental cancerology: in search of therapeutic models].
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
[No Abstract] [Full Text] [Related]
7. [An experimental study of the antitumor properties of olipifat].
Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
[TBL] [Abstract][Full Text] [Related]
8. [Experimental study of the antitumor effect of Z-100 in the treatment of MM 46 tumor transplanted in C3H/He mice. 1. Effect of long-term administration of Z-100].
Ogawa Y; Inomata T; Yoshida S; Maeda T; Seguchi H
Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2551-8. PubMed ID: 3209924
[No Abstract] [Full Text] [Related]
9. [Biological effects of leakadin].
Garin AM; Lichinitser MR; Dmitrieva NV; Rubtsov BI; Leneva NV
Vopr Onkol; 1988; 34(2):192-6. PubMed ID: 2964757
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic strategies for neoplasia.
Talmadge JE
Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
[No Abstract] [Full Text] [Related]
11. Can oxysterols have some interest in the treatment of tumors?
Beck JP
Prog Clin Biol Res; 1990; 348():71-93. PubMed ID: 2201035
[No Abstract] [Full Text] [Related]
12. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
13. Medicine. Building better mouse models for studying cancer.
Marx J
Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
[No Abstract] [Full Text] [Related]
14. [Experimental substantiation of the clinical use of the enzymatic blood preparation, ceruloplasmin].
Pinchuk VG; Berdinskikh NK; Voloshchenko IuV
Vestn Akad Med Nauk SSSR; 1985; (1):22-7. PubMed ID: 3976284
[No Abstract] [Full Text] [Related]
15. The dose-response effect: a critical analysis.
Amadori S
Bone Marrow Transplant; 1991; 7 Suppl 2():154-6. PubMed ID: 1878690
[No Abstract] [Full Text] [Related]
16. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].
Savran VR
Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347
[No Abstract] [Full Text] [Related]
17. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
Skipper HE; Simpson-Herren L
Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
[No Abstract] [Full Text] [Related]
18. [The pharmacological properties of preparations from the aziridinyl triazine group].
Stukov AN; Filov VA; Kon'kov SA; Ivin BA
Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral effects of lipid A: preclinical and clinical studies.
Pance A; Reisser D; Jeannin JF
J Investig Med; 2002 May; 50(3):173-8. PubMed ID: 12033281
[No Abstract] [Full Text] [Related]
20. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
Hansen K; Khanna C
Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
